InsiderTrades.com logo
Download Our Tesla Ebook For Free
From DTI   |   Ad
Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.
To claim your copy free of charge simply follow this link.

HRTX Insider Trading

Insider Ownership Percentage: 5.76%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Heron Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Heron Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Heron Therapeutics Share Price & Price History

Current Price: $1.09
Price Change: ▼ Price Decrease of -0.035 (-3.13%)
As of 11/21/2024 02:20 PM ET

This chart shows the closing price history over time for HRTX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Tesla Execs are Freaking Out
From Angel Publishing   |   Ad
It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.
Click here to get the details.

Heron Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/16/2023Craig A CollardCEOBuy150,000$0.92$138,000.00186,496View SEC Filing Icon  
11/16/2023Ira DuarteCFOBuy85,000$0.89$75,650.0085,000View SEC Filing Icon  
11/16/2023William P ForbesEVPBuy50,000$0.94$47,000.0054,000View SEC Filing Icon  
7/21/2023Adam MorganDirectorBuy2,486,744$1.37$3,406,839.286,986,744View SEC Filing Icon  
5/3/2022Kimberly ManhardEVPSell1,504$4.76$7,159.0410,872View SEC Filing Icon  
12/21/2021Christian WaageDirectorSell300$9.73$2,919.00View SEC Filing Icon  
See Full Table
JD Vance Predicts: Wall Street vs. Trump & Your Money
From Priority Gold   |   Ad
Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.
Get your free guide NOW before it's too late.

SEC Filings (Institutional Ownership Changes) for Heron Therapeutics (NASDAQ:HRTX)

80.01% of Heron Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at HRTX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Heron Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/19/2024Barclays PLC218,455$0.43M0.0%+29.8%0.144%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC3,045,361$6.06M0.0%-2.2%2.002%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC218,455$0.43M0.0%+29.8%0.144%Search for SEC Filing on Google Icon
11/15/2024Y Intercept Hong Kong Ltd19,629$39K0.0%N/A0.013%Search for SEC Filing on Google Icon
11/15/2024XTX Topco Ltd297,568$0.59M0.0%+449.0%0.196%Search for SEC Filing on Google Icon
11/15/2024Zacks Investment Management475,575$0.95M0.0%+2.4%0.313%Search for SEC Filing on Google Icon
11/15/2024Jane Street Group LLC332,126$0.66M0.0%-5.4%0.218%Search for SEC Filing on Google Icon
11/15/2024Wellington Management Group LLP496,227$0.99M0.0%-4.8%0.326%Search for SEC Filing on Google Icon
11/15/2024State Street Corp3,192,436$6.35M0.0%-39.5%2.099%Search for SEC Filing on Google Icon
11/15/2024Clearline Capital LP2,226,512$4.43M0.2%+48.9%1.464%Search for SEC Filing on Google Icon
11/14/2024Verition Fund Management LLC108,115$0.22M0.0%+340.0%0.071%Search for SEC Filing on Google Icon
11/14/2024Capstone Investment Advisors LLC22,666$45K0.0%N/A0.015%Search for SEC Filing on Google Icon
11/13/2024Glenmede Trust Co. NA31,903$63K0.0%+49.6%0.021%Search for SEC Filing on Google Icon
11/13/2024BNP Paribas Financial Markets275,946$0.55M0.0%+50.4%0.182%Search for SEC Filing on Google Icon
11/13/2024FMR LLC431,906$0.86M0.0%+26.2%0.285%Search for SEC Filing on Google Icon
11/12/2024Pekin Hardy Strauss Inc.15,170$30K0.0%-39.7%0.010%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.1,096,385$2.18M0.0%-3.6%0.723%Search for SEC Filing on Google Icon
11/9/2024Intech Investment Management LLC35,988$72K0.0%N/A0.024%Search for SEC Filing on Google Icon
11/6/2024King Wealth Management Group23,299$46K0.0%+52.3%0.015%Search for SEC Filing on Google Icon
11/5/2024GSA Capital Partners LLP512,736$1.02M0.1%+18.4%0.338%Search for SEC Filing on Google Icon
11/4/2024Los Angeles Capital Management LLC220,834$0.44M0.0%-7.6%0.146%Search for SEC Filing on Google Icon
10/31/2024Principal Financial Group Inc.102,651$0.20M0.0%+456.5%0.068%Search for SEC Filing on Google Icon
10/25/2024Cutter & CO Brokerage Inc.19,535$39K0.0%N/A0.013%Search for SEC Filing on Google Icon
10/24/2024Wealth Enhancement Advisory Services LLC45,273$90K0.0%+21.2%0.030%Search for SEC Filing on Google Icon
10/22/2024Searle & CO.86,250$0.17M0.0%+684.1%0.057%Search for SEC Filing on Google Icon
10/16/2024Firethorn Wealth Partners LLC26,013$52K0.0%N/A0.017%Search for SEC Filing on Google Icon
10/9/2024Congress Park Capital LLC1,978,078$3.94M1.5%+25.3%1.313%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC70,917$0.14M0.0%-64.2%0.047%Search for SEC Filing on Google Icon
8/19/2024B. Riley Wealth Advisors Inc.11,602$41K0.0%N/A0.008%Search for SEC Filing on Google Icon
8/16/2024Clearline Capital LP1,495,266$5.23M0.1%-46.1%0.993%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company45,771$0.16M0.0%+16.0%0.030%Search for SEC Filing on Google Icon
8/15/2024Millennium Management LLC1,434,627$5.02M0.0%-54.7%0.952%Search for SEC Filing on Google Icon
8/15/2024AQR Capital Management LLC607,135$2.13M0.0%+1,460.9%0.403%Search for SEC Filing on Google Icon
8/15/2024Caxton Associates LP202,157$0.71M0.0%N/A0.134%Search for SEC Filing on Google Icon
8/14/2024Squarepoint Ops LLC363,700$1.27M0.0%+369.0%0.241%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP1,761,051$6.16M0.0%+256.2%1.169%Search for SEC Filing on Google Icon
8/14/2024Profund Advisors LLC48,073$0.17M0.0%N/A0.032%Search for SEC Filing on Google Icon
8/13/2024Sei Investments Co.12,685$44K0.0%N/A0.008%Search for SEC Filing on Google Icon
8/13/2024Orchard Capital Management LLC2,243,426$7.85M2.4%-1.3%1.489%Search for SEC Filing on Google Icon
8/12/2024Richmond Brothers Inc.356,558$1.25M2.5%+20.2%0.237%Search for SEC Filing on Google Icon
8/12/2024XTX Topco Ltd54,205$0.19M0.0%-74.0%0.036%Search for SEC Filing on Google Icon
8/12/2024E Fund Management Co. Ltd.15,642$55K0.0%N/A0.010%Search for SEC Filing on Google Icon
8/10/2024Wealth Alliance32,000$0.11M0.0%+60.0%0.021%Search for SEC Filing on Google Icon
8/9/2024Pekin Hardy Strauss Inc.25,170$88K0.0%-19.2%0.017%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC1,993,800$6.98M0.0%-17.1%1.323%Search for SEC Filing on Google Icon
8/7/2024Headlands Technologies LLC90,495$0.32M0.0%+731.3%0.060%Search for SEC Filing on Google Icon
8/7/2024Monaco Asset Management SAM1,513,164$5.30M0.8%-16.5%1.004%Search for SEC Filing on Google Icon
8/6/2024Acadian Asset Management LLC36,462$0.13M0.0%N/A0.024%Search for SEC Filing on Google Icon
8/6/2024Los Angeles Capital Management LLC238,899$0.84M0.0%-51.6%0.159%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers184,472$0.65M0.0%+31.5%0.122%Search for SEC Filing on Google Icon
7/31/2024nVerses Capital LLC7,800$27K0.0%N/A0.005%Search for SEC Filing on Google Icon
7/30/2024Searle & CO.11,000$38K0.0%-87.2%0.007%Search for SEC Filing on Google Icon
7/29/2024Principal Financial Group Inc.18,446$65K0.0%-49.0%0.012%Search for SEC Filing on Google Icon
7/29/2024Panagora Asset Management Inc.562,228$1.97M0.0%+49.8%0.373%Search for SEC Filing on Google Icon
7/27/2024HB Wealth Management LLC10,000$35K0.0%N/A0.007%Search for SEC Filing on Google Icon
7/26/2024Legato Capital Management LLC239,239$0.84M0.1%N/A0.159%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp449,212$1.57M0.0%+33.9%0.298%Search for SEC Filing on Google Icon
7/24/2024Zweig DiMenna Associates LLC128,592$0.45M0.1%-59.8%0.085%Search for SEC Filing on Google Icon
7/22/2024Capital Investment Counsel Inc14,625$51K0.0%+27.2%0.010%Search for SEC Filing on Google Icon
7/17/2024Baader Bank Aktiengesellschaft36,128$0.13M0.0%N/A0.024%Search for SEC Filing on Google Icon
7/16/2024Apeiron RIA LLC188,635$0.66M0.2%+52.1%0.125%Search for SEC Filing on Google Icon
7/12/2024Congress Park Capital LLC1,578,501$5.53M2.2%-4.0%1.048%Search for SEC Filing on Google Icon
7/12/2024SG Americas Securities LLC198,186$0.69M0.0%N/A0.132%Search for SEC Filing on Google Icon
7/10/2024Valeo Financial Advisors LLC12,747$45K0.0%N/A0.008%Search for SEC Filing on Google Icon
5/16/2024California State Teachers Retirement System10,409$29K0.0%-38.9%0.007%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD29,922$83K0.0%+15.4%0.020%Search for SEC Filing on Google Icon
5/14/2024CM Management LLC300,000$0.83M0.7%-7.7%0.199%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.8,114,716$22.48M0.0%-2.7%5.387%Search for SEC Filing on Google Icon
5/9/2024Monaco Asset Management SAM1,813,164$5.02M1.5%-18.6%1.204%Search for SEC Filing on Google Icon
5/9/2024State Board of Administration of Florida Retirement System40,705$0.11M0.0%+51.4%0.027%Search for SEC Filing on Google Icon
5/8/2024Headlands Technologies LLC10,886$30K0.0%N/A0.007%Search for SEC Filing on Google Icon
5/7/2024Susquehanna Fundamental Investments LLC11,727$32K0.0%N/A0.008%Search for SEC Filing on Google Icon
5/3/2024GSA Capital Partners LLP279,699$0.78M0.1%-17.6%0.186%Search for SEC Filing on Google Icon
5/1/2024BNP Paribas Financial Markets51,296$0.14M0.0%+80.7%0.034%Search for SEC Filing on Google Icon
5/1/2024Mirae Asset Global Investments Co. Ltd.32,615$90K0.0%N/A0.022%Search for SEC Filing on Google Icon
4/30/2024Commonwealth Equity Services LLC338,526$0.94M0.0%+3.1%0.225%Search for SEC Filing on Google Icon
4/18/2024Diversified Trust Co23,966$66K0.0%N/A0.016%Search for SEC Filing on Google Icon
4/16/2024Congress Park Capital LLC1,644,785$4.56M2.0%-8.6%1.094%Search for SEC Filing on Google Icon
4/5/2024Los Angeles Capital Management LLC493,264$1.37M0.0%-4.1%0.328%Search for SEC Filing on Google Icon
2/15/2024Orchard Capital Management LLC2,243,426$3.81M1.2%+4.7%1.495%Search for SEC Filing on Google Icon
2/9/2024JW Asset Management LLC2,292,418$3.90M2.2%-4.8%1.528%Search for SEC Filing on Google Icon
2/9/2024Franklin Resources Inc.6,404,795$10.89M0.0%-8.0%4.268%Search for SEC Filing on Google Icon
2/9/2024D.A. Davidson & CO.30,100$51K0.0%-25.9%0.020%Search for SEC Filing on Google Icon
2/8/2024Richmond Brothers Inc.296,706$0.50M0.9%+188.0%0.198%Search for SEC Filing on Google Icon
2/8/2024Panagora Asset Management Inc.139,113$0.24M0.0%N/A0.093%Search for SEC Filing on Google Icon
2/7/2024Monaco Asset Management SAM2,226,475$3.79M1.1%+219.5%1.484%Search for SEC Filing on Google Icon
2/6/2024Los Angeles Capital Management LLC514,377$0.87M0.0%+49.9%0.343%Search for SEC Filing on Google Icon
2/5/2024Victory Capital Management Inc.19,929$34K0.0%+30.2%0.013%Search for SEC Filing on Google Icon
2/5/2024Pekin Hardy Strauss Inc.36,470$62K0.0%-38.3%0.024%Search for SEC Filing on Google Icon
1/31/2024Knights of Columbus Asset Advisors LLC83,482$0.14M0.0%+100.0%0.056%Search for SEC Filing on Google Icon
1/30/2024ACT Advisors LLC.22,145$38K0.0%N/A0.015%Search for SEC Filing on Google Icon
1/19/2024Congress Park Capital LLC1,798,650$3.06M1.5%+205.3%1.199%Search for SEC Filing on Google Icon
1/16/2024Raymond James Financial Services Advisors Inc.48,309$82K0.0%+61.2%0.032%Search for SEC Filing on Google Icon
11/15/2023Tejara Capital Ltd2,109,681$2.17M1.2%+28.6%1.499%Search for SEC Filing on Google Icon
11/15/2023Rubric Capital Management LP26,713,503$27.52M1.0%+127.3%18.978%Search for SEC Filing on Google Icon
11/15/2023Adage Capital Partners GP L.L.C.2,000,000$2.06M0.0%+100.0%1.421%Search for SEC Filing on Google Icon
11/13/2023Tejara Capital Ltd2,109,681$2.17M1.6%+28.6%1.499%Search for SEC Filing on Google Icon
11/9/2023JW Asset Management LLC2,407,418$2.48M1.1%+9.1%1.710%Search for SEC Filing on Google Icon
11/8/2023D.A. Davidson & CO.40,600$42K0.0%-84.2%0.029%Search for SEC Filing on Google Icon
11/8/2023Pekin Hardy Strauss Inc.59,095$61K0.0%-44.3%0.042%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Heron Therapeutics logo
Heron Therapeutics, Inc., a commercial-stage biotechnology company, focuses on enhancing the lives of patients by developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing ZYNRELEF, a dual-acting local anesthetic that delivers a fixed-dose combination of the local anesthetic bupivacaine and a low dose of the nonsteroidal anti-inflammatory drug meloxicam; and APONVIE, an intravenous formulation of a substance P/neurokinin-1 receptor antagonist indicated for the prevention of postoperative nausea and vomiting in adults. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in San Diego, California.
Read More on Heron Therapeutics

Today's Range

Now: $1.09
Low: $1.05
High: $1.12

50 Day Range

MA: $1.78
Low: $1.12
High: $2.12

52 Week Range

Now: $1.09
Low: $1.04
High: $3.93

Volume

857,363 shs

Average Volume

2,402,939 shs

Market Capitalization

$165.03 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.81

Who are the company insiders with the largest holdings of Heron Therapeutics?

Heron Therapeutics' top insider shareholders include:
  1. Adam Morgan (Director)
  2. Craig A Collard (CEO)
  3. Ira Duarte (CFO)
  4. William P Forbes (EVP)
Learn More about top insider investors at Heron Therapeutics.

Who are the major institutional investors of Heron Therapeutics?

Heron Therapeutics' top institutional shareholders include:
  1. State Street Corp — 2.10%
  2. Geode Capital Management LLC — 2.00%
  3. Clearline Capital LP — 1.46%
  4. Congress Park Capital LLC — 1.31%
  5. Charles Schwab Investment Management Inc. — 0.72%
  6. GSA Capital Partners LLP — 0.34%
Learn More about top institutional investors of Heron Therapeutics stock.

Which institutional investors are selling Heron Therapeutics stock?

Within the last quarter, HRTX stock was sold by these institutional investors:
  1. State Street Corp
  2. SG Americas Securities LLC
  3. Geode Capital Management LLC
  4. Charles Schwab Investment Management Inc.
  5. Wellington Management Group LLP
  6. Jane Street Group LLC
  7. Los Angeles Capital Management LLC
  8. Pekin Hardy Strauss Inc.

Which institutional investors are buying Heron Therapeutics stock?

In the previous quarter, HRTX stock was bought by institutional investors including:
  1. Clearline Capital LP
  2. Congress Park Capital LLC
  3. XTX Topco Ltd
  4. BNP Paribas Financial Markets
  5. FMR LLC
  6. Principal Financial Group Inc.
  7. Verition Fund Management LLC
  8. GSA Capital Partners LLP
Within the last year, these company insiders have bought Heron Therapeutics stock:
  1. Adam Morgan (Director)
  2. Craig A Collard (CEO)
  3. Ira Duarte (CFO)
  4. William P Forbes (EVP)
Learn More investors buying Heron Therapeutics stock.
Download Our Tesla Ebook For Free
From DTI   |   Ad
Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.
To claim your copy free of charge simply follow this link.